Health Trials

Malignant Plasma Cell Neoplasms

1

Review clinical trials related to Malignant Plasma Cell Neoplasms. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

QLS4131 Combination Therapy in Malignant Plasma Cell Neoplasms

The purpose of the study is to compare the efficacy of QLS4131(SC) in combination with QL2109, with or without pomalidomide or lenalidomide, and QLS4131 (SC) in combination with QL2109, and QLS4131 (SC) in combination with Pomalidomide, and QLS4131(SC) in combination with QL2109 and Lenalidomide.

Participants needed: 162
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Qilu Pharmaceutical Co., Ltd.Updated: May 1, 2026
Eligibility criteria

Serum M-protein ≥0.5 g/dL (5 g/L); [+2]

History of Grade 3 or higher cytokine release syndrome (CRS) associated with any... [+9]

Read more